These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

853 related items for PubMed ID: 19252062

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of chronic gap junction conduction-enhancing antiarrhythmic peptide GAP-134 administration on experimental atrial fibrillation in dogs.
    Laurent G, Leong-Poi H, Mangat I, Moe GW, Hu X, So PP, Tarulli E, Ramadeen A, Rossman EI, Hennan JK, Dorian P.
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):171-8. PubMed ID: 19808462
    [Abstract] [Full Text] [Related]

  • 3. Discovery of (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride (GAP-134)13, an orally active small molecule gap-junction modifier for the treatment of atrial fibrillation.
    Butera JA, Larsen BD, Hennan JK, Kerns E, Di L, Alimardanov A, Swillo RE, Morgan GA, Liu K, Wang Q, Rossman EI, Unwalla R, McDonald L, Huselton C, Petersen JS.
    J Med Chem; 2009 Feb 26; 52(4):908-11. PubMed ID: 19175320
    [Abstract] [Full Text] [Related]

  • 4. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
    Shiroshita-Takeshita A, Sakabe M, Haugan K, Hennan JK, Nattel S.
    Circulation; 2007 Jan 23; 115(3):310-8. PubMed ID: 17224477
    [Abstract] [Full Text] [Related]

  • 5. Termination of Atrial Flutter and Fibrillation by K201's Metabolite M-II: Studies in the Canine Sterile Pericarditis Model.
    Sadrpour SA, Serhal M, Khrestian CM, Lee S, Fields T, Dittrich HC, Waldo AL.
    J Cardiovasc Pharmacol; 2015 May 23; 65(5):494-9. PubMed ID: 25636078
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
    Kumar K, Nearing BD, Carvas M, Nascimento BC, Acar M, Belardinelli L, Verrier RL.
    J Cardiovasc Electrophysiol; 2009 Jul 23; 20(7):796-802. PubMed ID: 19298570
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Electrophysiologic effects of a new class III antiarrhythmic agent, E-4031, on atrial flutter, atrial refractoriness, and conduction delay in a canine sterile pericarditis model.
    Shimizu A, Kaibara M, Centurion OA, Kapuku G, Hirata T, Fukatani M, Yano K, Hashiba K.
    J Cardiovasc Pharmacol; 1993 Apr 23; 21(4):656-62. PubMed ID: 7681913
    [Abstract] [Full Text] [Related]

  • 11. Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model.
    Goldstein RN, Khrestian C, Carlsson L, Waldo AL.
    J Cardiovasc Electrophysiol; 2004 Dec 23; 15(12):1444-50. PubMed ID: 15610294
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs.
    Sarrazin JF, Comeau G, Daleau P, Kingma J, Plante I, Fournier D, Molin F.
    J Am Coll Cardiol; 2007 Oct 09; 50(15):1505-12. PubMed ID: 17919572
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
    Zhang HC, Guo JH, Fang Q, Zheng YA, Sun YM, Zhu WQ, Wan Z, Guo JX, Ge JB, Han SM.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 30; 85(12):798-801. PubMed ID: 15949393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.